Submit the form and set up a meeting with a Novotech expert if you wish to hear more about the world’s fastest growing region in clinical development.
Novotech has extensive experience in cell & gene therapy clinical trials across Asia Pacific. With this experience, we are proud to announce that Novotech, the leading Asia Pacific biotech specialist CRO, has been awarded the Cell & Gene Therapy Clinical Trials award at the 6th Cell & Gene Therapy World Asia 2022 conference.
If you are considering APAC or US for your clinical trials, it would be a great opportunity to connect during the Cell and Gene Meeting on the Mesa to learn more about your plans and see if/how we can support your clinical development plans over 2022 and beyond. Australia is a very attractive destination for early phase clinical trials (43.5% cash rebate on clinical trial expenses, rapid start-up with no IND required), while the growth comparison of Asia, particularly China versus the rest of the world, shows China having the fastest growth rate of 18% CAGR in the overall Cell and Gene therapy trials.
